Dec 3, 2020
After a decade of work, COVID-19 vaccines are the first RNA vaccines to be put through the paces of clinical trials. But what sets RNA vaccine technology apart from more traditional methods and how might this new platform be used going forward? Hopkins immunologist Dr. Diane Griffin talks with Stephanie Desmon about RNA vaccines, what they are and why they’re different, complications that still need to be worked out, and how this groundbreaking new platform could help vaccinate us against future outbreaks.
KEYWORDS: vaccine development